Susan Conrad is a Professor in the Department of Microbiology and Molecular Genetics. Her research focuses on the mechanisms by which estrogen and antiestrogens regulate the cell cycle in human breast cancer cells.
Dr. Conrad received her Ph.D. from the California Institute of Technology and completed her postdoctoral training at the University of California, Berkeley.
Dr. Conrad’s laboratory identifies changes that occur in breast tumor cells as they progress to an antiestrogen resistant phenotype, which causes treatment failure in many breast cancer patients. The lab also studies the patterns of gene regulation by estrogen in a mouse model of menopause. While estrogen treatment offers post-menopausal women protection against several diseases, including osteoporosis and cardiovascular disease, it also increases the risk of uterine and breast cancer. As such, Dr. Conrad and her team aim to identify Selective Estrogen Receptor Modulators that can provide the benefits of estrogen treatment without the associated risks.